Drug intelligence / Profile preview

valproic acid + corticosteroids

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal, Topical, Inhalation
01

Overview

This is a combination of valproic acid, an anticonvulsant and mood stabilizer, and corticosteroids, a class of steroid hormones with potent anti-inflammatory and immunosuppressive properties. Valproic acid increases GABAergic neurotransmission in the brain by inhibiting GABA transaminase and succinic semialdehyde dehydrogenase, suppresses voltage-gated sodium channels, and modulates signaling pathways involved in neuroplasticity. It is primarily used to treat epilepsy (various seizure types), bipolar disorder (mania), and for migraine prophylaxis[1][2][5]. Corticosteroids such as prednisone or betamethasone act via glucocorticoid receptors to regulate gene expression, leading to reduced inflammation and immune response[9]. The combination may be considered in clinical scenarios where both neurological stabilization (e.g., seizure control or mood stabilization) and immunosuppression/anti-inflammation are required. There is some evidence for using valproic acid alongside corticosteroids to manage psychiatric side effects induced by steroids without discontinuing steroid therapy[6][7].

02

Targets

SSADH (Succinate-semialdehyde dehydrogenase)UGT2B7 (UDP-glucuronosyltransferase 2B7)UGT1A9 (UDP-glucuronosyltransferase 1A9)GR (Glucocorticoid receptor)HDAC (HDAC family)NaV (Voltage-gated sodium channels)ABAT (4-aminobutyrate aminotransferase)UGT2B15 (UDP-glucuronosyltransferase 2B15)

Beyond the preview

Go deeper on valproic acid + corticosteroids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on valproic acid + corticosteroids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call